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Background: The eﬀects of upgrading from right ventricular (RV) pacing to cardiac
resynchronization therapy (CRT) in patients with heart failure remains unclear. The aim of
this study was to evaluate the improvement of cardiac function in patients upgraded from RV
pacing to CRT.
Methods: We studied 48 consecutive patients who underwent CRT implantation, and were
followed up for more than 6 months. This group included 15 patients who were upgraded
from RV pacing. We measured left ventricular (LV) dp/dt to determine the timing of LV-RV
sequential pacing. Echocardiographic examination was performed before and 6–12 months
after the CRT procedure to assess the LV ejection fraction (LVEF).
Results: In overall patients, LVEF increased after CRT (31:4 9:8 vs. 37:1 13:6%,
p ¼ 0:005). The increase of LVEF was more signiﬁcant in the upgrade group (31:3 9:4% to
41:9 13:9%, p ¼ 0:01) than in the newly implanted group (31:5 10:1% to 35:0 13:1%,
p ¼ 0:13). An increase of dp/dt during CRT was signiﬁcantly positively associated with an
increase of LVEF (r ¼ 0:74, p ¼ 0:01) in overall patients.
Conclusion: The upgrading from RV pacing to CRT was associated with greater
improvement of LV systolic function than de novo CRT implantation. The change of dp/dt
might be useful to predict the improvement of LV systolic function.
(J Arrhythmia 2010; 26: 16–20)
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Introduction
Intra- and/or inter-ventricular dyssynchrony can
cause heart failure via a hemodynamic mechanism.
Cardiac resynchronization therapy (CRT) has proven
beneﬁcial for heart failure patients with either type
of dyssynchrony.1–5)
It has also been reported that a change in right
ventricular (RV) pacing can induce intra- and/or
inter-ventricular dyssynchrony,6) and thereby an
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increase in the RV pacing ratio has been associated
with heart failure.7–9) The eﬀects of upgrading from
RV pacing to CRT have been investigated,10,11) but it
remains unclear how to evaluate the improvement of
cardiac function due to an upgrade from RV pacing
to CRT compares with de novo CRT cases.
The aim of this study was thus to evaluate the
improvement of cardiac function in patients upgrad-
ed from RV pacing to CRT in comparison with
patients initially implanted with CRT.
Patients and Methods
Patient population and baseline measurements
The study included 48 consecutive patients with
heart failure (mean age = 66:3 11:2 years, 33
male) with indications for CRT in accordance with
the guidelines of The Japanese Circulation Society.
Fifteen patients who were upgraded from right
ventricular pacing were included in this study group.
We compared the change of left ventricular systolic
function and QRS duration between patients upgrad-
ed from right ventricular pacing (upgrade group,
N ¼ 15) and patients newly implanted with a CRT
device (de novo group, N ¼ 33). Standard twelve-
lead electrocardiography was performed before and
a day after the CRT procedure. Echocardiographic
examination was performed before and 6–12 months
after the CRT procedure. Left ventricular ejection
fraction (LVEF) was assessed by Simpson’s equa-
tion using apical four-chamber and two-chamber
views.12)
Catheterization and stimulation protocol
Hemodynamic measurements were performed us-
ing a 4 Fr pigtail catheter during CRT implantation.
The catheter was advanced into the left ventricle
(LV) via the right femoral artery, and dp/dt and
blood pressure were calculated in real time by using
a digital ﬁlter. After placement of the pigtail
catheter, the heart was stimulated. The protocol
included single RV, LV and biventricular (BiV)
stimulation with either simultaneous (BiV0) or
sequential pacing. The optimal VV delay was
determined by the maximum dp/dt. We compared
the dp/dt and systolic blood pressure values at
baseline (de novo group: sinus rhythm; upgrade
group: RV pacing) with those at optimal VV delay.
We conducted the hemodynamic measurements in
11 patients (de novo group: 7 cases; upgrade group:
4 cases).
Statistical analysis
All data were expressed as the mean SD or a
percentage. An unpaired t-test and 2 test were used
for comparison of the mean values and parameters
between de novo group and upgrade group. A paired
t-test was used to analyze the change of LVEF. All
statistical analyses were performed using the com-
puter software package SPSS version 15.0J (SPSS
Inc., Chicago, IL). A probability value <0:05 was
considered statistically signiﬁcant.
Results
The baseline characteristics are shown in Table 1.
The de novo group had a greater proportion of male
patients (p ¼ 0:026), a greater rate of ischemic heart
disease (p ¼ 0:01), and a smaller mean QRS
duration (p < 0:01) than the upgrade group. The
diagnoses in the upgrade group were as follows: 9
cases of complete atrioventricular block, 2 cases of
advanced atrioventricular block, 3 cases of brady-
cardic atrial ﬁbrillation, and one case of sick sinus
syndrome. Underlying cardiac diseases in the up-
grade group were sarcoidosis (4 cases), valvular
disease (4 cases), hypertrophic cardiomyopathy (2
cases), hypertensive heart disease (2 cases), myo-
carditis (1 case), and unknown origin (2 cases). The
mean duration from the implantation of the pace-
maker to the upgrade to CRT was 8:2 7:3 years,
and the mean ventricular pacing ratio was 94 11%.
Table 1 Patient characteristics
Upgrade case
N ¼ 15
De novo case
N ¼ 33 P value
Age (years) 68.3  11.5 65.4  11.2 0.41
Male (%) 47 79 0.026
Deﬁbrillator (%) 53 79 0.08
Ischemic heart disease (%) 0 33 0.01
LVEF (%) 30 10 32 12 0.57
QRS duration (ms) 189 40 162 25 0.006
LVEF = left ventricular ejection fraction
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The pacing modes were as follows: in the upgrade
group, single-chamber (VVI) programming was used
in 4 cases and dual-chamber (DDD) programming in
11 cases; in the de novo group, VVI programming
was used in 5 cases and DDD programming in 28
cases.
In the overall patients, LVEF increased after CRT
(31:4 9:8 vs. 37:1 13:6%, p ¼ 0:005; Figure 1).
The increase of LVEF was signiﬁcant in the upgrade
group (31:3 9:4% to 41:9 13:9%, p ¼ 0:01;
Figure 1), but not in the de novo group (31:5
10:1% to 35:0 13:1%, p ¼ 0:13; Figure 1). LVEF
at baseline showed a nonsigniﬁcant tendency toward
association with QRS duration in the upgrade group
(r ¼ 0:48, p ¼ 0:068; Figure 2A), but not associ-
ated with QRS duration in the de novo group
(r ¼ 0:24, p ¼ 0:19; Figure 2B). However, a de-
crease of QRS duration after CRT was not associated
with an increase of LVEF in the upgrade group
Upgrade
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De novo
N=33
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N=48
50
40
30
20
LV
EF
 (%
)
P=0.005 P=0.13
P=0.01
Figure 1 Changes of LVEF in patients undergoing de novo
CRT or upgrading to CRT.
LVEF: left ventricular ejection fraction, Black bars = Baseline,
Grey bars = Post CRT
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Figure 2 The relationship between QRS duration and LVEF in the upgrade group (A) and the de novo group
(B). The relationship between the decrease of QRS duration and the increase of LVEF in the upgrade group (C)
and the de novo group (D).
LVEF: left ventricular ejection fraction.
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(r ¼ 0:16, p ¼ 0:62; Figure 2C) or in the de novo
group (r ¼ 0:09, p ¼ 0:65; Figure 2D). An increase
of dp/dt during CRT was signiﬁcantly positively
correlated with an increase of LVEF (r ¼ 0:74,
p ¼ 0:01; Figure 3) in overall patients, but an
increase of systolic blood pressure during CRT was
not associated with an increase of LVEF (r ¼ 0:24,
p ¼ 0:44).
Discussion
The main ﬁnding of this study was that upgrading
from RV pacing to CRT was more eﬀective in
improving left ventricular systolic function than de
novo CRT in patients with heart failure. In addition,
it was shown that an increase of dp/dt might be a
predictor of improvement in left ventricular systolic
function.
CRT is broadly indicated for patients with heart
failure who had inter- and/or intra-ventricular
dyssynchrony. In recent years, it has been reported
that an increase in the RV pacing ratio is associated
with heart failure,7–10) and thus cardiac dysfunction
due to RV pacing has become a serious problem.
However, there may be many patients who did not
have systolic dysfunction at the time their pacemaker
was implanted. In those cases, CRT could be
expected to be more eﬀective. There are many
patients who require RV pacing for symptomatic
bradycardia,13) and we cannot precisely predict the
future heart failure onset in such patients. Indeed, the
pacing ratio in the upgrade group was high and may
have been a cause of heart failure in the present
study, and the beneﬁcial eﬀects of upgrading from
RV pacing to CRT may have been due to simply
removing the problems caused by RV pacing.
However, a decrease of QRS duration did not predict
an increase of LVEF in our patients. This fact might
indicate that the QRS duration is not a precise
predictor of an improvement in cardiac dyssynchro-
ny. In any case, further studies will clearly be needed
to improve the response rate to CRT.
In the current study, an increase of dp/dt during
CRT was signiﬁcantly positively correlated with an
increase of LVEF. A recent study has shown that
an increase in the LV dp/dt is one of the acute
hemodynamic eﬀects of BiV pacing.10) RV pacing
induces both interventricular dyssynchrony (between
the RV and the LV), as well as intraventricular
dyssynchrony (within the LV),6) and CRT mechan-
ically improves the dyssynchrony and results in
reverse remodeling.14,15) In the PROSPECT study,
although various markers of dyssynchrony contrib-
uted signiﬁcantly to the prediction of clinical out-
come, the sensitivity and speciﬁcity of these markers
were modest.16) The optimization of CRT might be
useful to improve clinical outcome because of the
increase of dp/dt, and might be helpful to increase
the response rate for CRT.
This study has some limitations. First, we did not
evaluate cardiac dyssynchrony using echocardiogra-
phy, although we believe that upgrading to CRT
might have achieved a more beneﬁcial eﬀect than de
novo CRT through an improvement of cardiac
dyssynchrony. Further studies, including an assess-
ment of echocardiologic dyssynchrony, will be
needed to clarify the beneﬁcial eﬀects of upgrading
from RV pacing to CRT in patients with heart
failure. In addition, we did not estimate LVEF
immediately following implantation of the pace-
maker in all cases in the upgrade group, and thus we
could not evaluate worsening cardiac function due
to RV pacing chronologically. Analysis on the
relationship between dp/dt during CRT and an
increase of LVEF was included in a part of this
study. Future studies will also be needed to verify
this relationship.
Conclusions
Upgrading from right ventricular pacing to CRT
was associated with a greater improvement of left
ventricular systolic function than de novo CRT in
patients with heart failure. The beneﬁcial eﬀects of
upgrading from RV pacing to CRT may be due to
simple removal of the problems caused by RV
pacing. The changes in dp/dt at the CRT procedure
might be useful to predict the improvement of left
ventricular systolic function after CRT.
150
100
50
0
-50
EF
 in
cr
ea
se
 (%
)
0 20 40 60
Δ
Δ
r=0.74
p=0.01
N=11
dp/dt increase (%)
Figure 3 The relationship between dp/dt increase and
LVEF increase.
LVEF: left ventricular ejection fraction.
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